M 771
Pill imprint M 771 has been identified as Cyclobenzaprine hydrochloride 5 mg.
Cyclobenzaprine is used in the treatment of muscle spasm; sciatica; migraine; fibromyalgia; temporomandibular joint disorder and belongs to the drug class skeletal muscle relaxants. There is no proven risk in humans during pregnancy.
Cyclobenzaprine 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Cyclobenzaprine hydrochloride Images
- Imprint:
-
M
771 - Strength:
- 5 mg
- Color:
- Blue
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
hypromellose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin
FD&C Blue No. 2
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0771
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55289-0236 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More Cyclobenzaprine Hydrochloride resources
- Cyclobenzaprine
- Cyclobenzaprine (Wolters Kluwer)
- Cyclobenzaprine Extended-Release Capsules (Wolters Kluwer)
- cyclobenzaprine (Cerner Multum)
- cyclobenzaprine (Micromedex) - Includes Dosage Information
- Cyclobenzaprine (AHFS DI)
- Cyclobenzaprine (FDA)
- Cyclobenzaprine Capsules (FDA)
- Cyclobenzaprine Hydrochloride (Wolters Kluwer)


